| Primary information |
|---|
| sequence ID | Seq_5825 |
| Peptide sequence | NVKENIQDNISLF |
| CancerPDF_ID | CancerPDF_ID767, CancerPDF_ID820, |
| PMID | 19795908,19795908 |
| Protein Name | Inter-alpha-trypsin inhibitor heavy chain H2,Inter-alpha-trypsin inhibitor heavy chain H2 |
| UniprotKB Entry Name | ITIH2_HUMAN,ITIH4_HUMAN |
| Fluid | Plasma,Plasma |
| M/Z | 767.39,767.39 |
| Charge | 2,2 |
| Mass (in Da) | NA,NA |
| fdr | NA,NA |
| Profiling Technique | LC-MS,LC-MS |
| Peptide Identification technique | MALDI-TOF/TOF,MALDI-TOF/TOF |
| Quantification Technique | LC-MRM (multiple reaction monitoring),LC-MRM (multiple reaction monitoring) |
| Labelled/Label Free | Labelled,Labelled |
| FDR | less than 7%,less than 7% |
| CancerPDF_ID | CancerPDF_ID767, CancerPDF_ID820, |
| p-Value | NA,NA |
| Software | FlexAnalysis 3.0 and Biotools 3.0 software,FlexAnalysis 3.0 and Biotools 3.0 software |
| Length | 13,13 |
| Cancer Type | Ductal adenocarcinoma of the pancreas (DAP),Ductal adenocarcinoma of the pancreas (DAP) |
| Database | NCBI refseq Protein Database,NCBI refseq Protein Database |
| Modification | NA,NA |
| Number of Patients | "41 normal, 23 patients","42 normal, 23 patients" |
| Regulation | NA,NA |
| Validation | NA,NA |
| Sensitivity | NA,NA |
| Specificity | NA,NA |
| Accuracy | NA,NA |
| Peptide Atlas | PeptideAtlas |
| IEDB | |